Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment resistant obsessive compulsive disorder / Maria Rosaria A. Muscatello en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 174-179 Título : Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment resistant obsessive compulsive disorder : A double blind, placebo controlled study Tipo de documento: texto impreso Autores: Maria Rosaria A. Muscatello, Autor ; Antonio Bruno, Autor ; Gianluca Pandolfo, Autor Fecha de publicación: 2022 Artículo en la página: pp. 174-179 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Aripiprazol, Inhibidores de la recaptación de serotonina, Clomipramina, Trastorno obsesivo-compulsivo Resumen: Based on the evidence that aripiprazole added to serotonin reuptake inhibitors (SRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder (OCD) has reported promising results, the present 16-week, double-blind, randomized, placebo-controlled trial had the aim to explore the efficacy of aripiprazole add-on pharmacotherapy on clinical symptoms and cognitive functioning in a sample of treatment-resistant OCD patients receiving SRIs. Link: ./index.php?lvl=notice_display&id=29386 [artículo] Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment resistant obsessive compulsive disorder : A double blind, placebo controlled study [texto impreso] / Maria Rosaria A. Muscatello, Autor ; Antonio Bruno, Autor ; Gianluca Pandolfo, Autor . - 2022 . - pp. 174-179. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 174-179 Palabras clave: Aripiprazol, Inhibidores de la recaptación de serotonina, Clomipramina, Trastorno obsesivo-compulsivo Resumen: Based on the evidence that aripiprazole added to serotonin reuptake inhibitors (SRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder (OCD) has reported promising results, the present 16-week, double-blind, randomized, placebo-controlled trial had the aim to explore the efficacy of aripiprazole add-on pharmacotherapy on clinical symptoms and cognitive functioning in a sample of treatment-resistant OCD patients receiving SRIs. Link: ./index.php?lvl=notice_display&id=29386

---

1 (1 - 1 / 1)